Capital markets

Homburger

Active across the full spectrum of capital markets transactions, Homburger is a tour-de-force when it comes to regulatory and tax aspects and is also highly experienced in managing international transactions for Swiss issuers and securities issues. The practice is jointly helmed by Frank Gerhard, who maintains a strong presence within the chemicals and life sciences sectors, and Benjamin Leisinger, who operates for a plethora of clients with regards to equity-linked and debt transactions. Dieter Gericke is well-positioned to advise on private placements within the life sciences sector, while Benedikt Maurenbrecher‘s arsenal of skills encompasses international bond offerings and covered bonds. Daniel Daeniker is well-versed in TMT and financial services sectors. Daniel Häusermann and Daniel Haeberli, who manages a range of securitised structured products, are other key names to note in the practice.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

‘Deep knowledge of complex capital markets, and they have the ability to manage major projects in a timely manner.'
'Attention to detail in a high volume of legal documents, provide precise and comprehensive reports.’
‘The team is unique due to a combination of specialised expertise, regulatory insight and strategic advisory skills.'
'The key aspects that make them stand out are deep knowledge of financial regulations, assistance in complex transaction structuring, international reach in handling cross border listings across multiple exchanges and several jurisdictions.’
‘They have strong subject matter mastery, as well as understanding of strategic insights and has clear and concise communication skills to breakdown complex legal concepts into basic teams, facilitating business decisions.’
‘Deep knowledge of the relevant legal aspects, very responsive comprehensive assumption of tasks while working very independently.’
‘Homburger responds to enquiries extremely quickly, reliably and, above all, competently. The contact is very uncomplicated.’
‘You can rely on their in-depth knowledge of the market and the applicable rules. You can also rely on them to deliver on time, even when time is tight. They are characterised by their pragmatic and solution-oriented approach.’

Key clients

Galderma
EQT
Meyer Burger
Santhera Pharmaceuticals
Jefferies
Leerink Partners
ADC Therapeutics
Nice & Green
UBS Group
Roche
Nestlé
DWS Group
AMAG Leasing
Basler Kantonalbank
Zürcher Kantonalbank
Stiftung PWG
Avolta
Thermo Fisher Scientific
J.P. Morgan
Goldman Sachs
Morgan Stanley
Bank Julius Bär
Luzerner Kantonalbank
Banque Pictet
Union Bancaire Privée
Citigroup
Bank J. Safra Sarasin

Work highlights

Advised Galderma and EQT as transaction counsel on Galderma’s $17bn IPO.
Advised Meyer Burger as legal and tax counsel on CHF206.75m deep discount rights offering.
Advised ADC Therapeutics on legal and tax aspects of $105m cross-border offering of shares and warrants.

Lawyers

Hall of Fame

The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.